Literature DB >> 28099197

Relative Frequencies of Arteritic and Nonarteritic Anterior Ischemic Optic Neuropathy in an Arab Population.

Anna M Gruener1, Jessica R Chang, Thomas M Bosley, Zakeya M Al-Sadah, Clarissa Kum, Timothy J McCulley.   

Abstract

BACKGROUND: To evaluate the relative frequencies of arteritic and nonarteritic anterior ischemic optic neuropathy (AION) in an Arab population and to compare and contrast these findings with known epidemiological data from Caucasian populations.
METHODS: A retrospective review of the medical records of all patients diagnosed with AION at the King Khaled Eye Specialist Hospital (KKESH) in Riyadh, Saudi Arabia, between 1997 and 2012.
RESULTS: Of 171 patients with AION, 4 had biopsy-proven giant-cell arteritis (GCA). The relative frequencies of arteritic anterior ischemic optic neuropathy (AAION) and nonarteritic anterior ischemic optic neuropathy (NAION) in this Arab cohort were 2.3% and 97.7%, respectively.
CONCLUSIONS: The relative frequencies of arteritic anterior ischemic optic neuropathy and nonarteritic anterior ischemic optic neuropathy differ between Arab and North American clinic-based populations, with giant-cell arteritis-related ischemia being much less frequent in Saudi Arabia.

Entities:  

Mesh:

Year:  2017        PMID: 28099197     DOI: 10.1097/WNO.0000000000000491

Source DB:  PubMed          Journal:  J Neuroophthalmol        ISSN: 1070-8022            Impact factor:   3.042


  2 in total

1.  Demographics and etiologic characteristics of non-glaucomatous optic atrophy: a single-center cross-sectional study from Turkey.

Authors:  Oğuzhan Kılıçarslan; Aslıhan Yılmaz Çebi; Bilge Batu Oto; Rengin Yıldırım
Journal:  Int Ophthalmol       Date:  2022-05-13       Impact factor: 2.029

2.  The Efficacy of Glucocorticoids in the Treatment of Nonarteritic Anterior Ischemic Optic Neuropathy: A Systematic Review and Meta-Analysis.

Authors:  Pingping Zhou; Jian Zhang; Yanxiu Qi
Journal:  Comput Math Methods Med       Date:  2022-03-18       Impact factor: 2.238

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.